Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Indian Journal of Surgical Oncology
Published in: Indian Journal of Surgical Oncology 2/2016

01-06-2016 | Review Article

Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies

Authors: Ramakrishnan Ayloor Seshadri, Hemanth Raj E

Published in: Indian Journal of Surgical Oncology | Issue 2/2016

Login to get access

Abstract

The introduction of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has led to an improvement in the survival of select patients with peritoneal surface malignancies (PSM). However, it is important to carefully identify patients who will benefit from this procedure and to avoid an unnecessary laparotomy in those who will not. The currently available imaging modalities are unable to accurately predict the peritoneal cancer index (PCI) score or the completeness of cytoreduction. In this article, we review the current status of staging laparoscopy in the assessment of patients with PSM who are planned for CRS & HIPEC. We discuss the patient selection, techniques, complications and efficacy of staging laparoscopy. To summarise, staging laparoscopy is a safe and feasible method of pre-operative assessment of patients with PSM. It has a high sensitivity and positive predictive value in identifying patients who can undergo a complete cytoreduction, thereby preventing many patients from undergoing an unnecessary laparotomy. With the exception of pseudomyxoma peritonei, it should be considered as a part of the routine assessment of patients with PSM who are being considered for CRS & HIPEC.
Literature
1.
Glehen O, Gilly F, Boutitie F, et al. (2010) Toward curative treatment of peritoneal carcinomatosis from nonovarian origin by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy a multi-institutional study of 1290 patients. Cancer 116:5608–5618CrossRefPubMed
2.
Chua TC, Moran BJ, Sugarbaker PH, et al. (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456CrossRefPubMed
3.
Yan TD, Deraco M, Baratti D, et al. (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutionalexperience. J Clin Oncol 27(36):6237–6242CrossRefPubMed
4.
Verwaal VJ, van Ruth S, de Bree E, et al. (2003) Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 21:3737–3743CrossRefPubMed
5.
Elias D, Gilly F, Boutitie F, et al. (2010) Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study. J Clin Oncol 28:63–68CrossRefPubMed
6.
Quenet F, D G, SS M, et al. (2011) Results of two bi-institutional prospective studies using intraperitoneal oxaliplatin with or without irinotecan during HIPEC after cytoreductive surgery for colorectal carcinomatosis. Ann Surg 254:294–301CrossRefPubMed
7.
Yonemura Y, Kawamura T, Bandou E, Takahashi S, Sawa T, Matsuki N (2005) Treatment of peritoneal dissemination from gastric cancer by peritonectomy and chemohyperthermic peritoneal perfusion. Br J Surg 92:370–375CrossRefPubMed
8.
Olivier Glehen, François Noel Gilly, Catherine Arvieux, Eddy Cotte, Florent Boutitie, Baudouin Mansvelt, Jean Marc Bereder, Gérard Lorimier, François Quenet, Dominique Elias and Association Française de Chirurgie (2010) Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol 17:2370–2377
9.
Mohamed F, Moran BJ (2009) Morbidity and mortality with cytoreductive surgery and intraperitoneal chemotherapy: the importance of a learning curve. Cancer J 15(3):196–199CrossRefPubMed
10.
Chua TC, Yan TD, Saxena A, Morris DL (2009) Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? a systematic review of morbidity and mortality. Ann Surg 249(6):900–907CrossRefPubMed
11.
12.
Van Sweringen HL, Hanseman DJ, Ahmad SA, Edwards MJ, Sussman JJ (2012) Predictors of survival in patients with high-grade peritoneal metastases undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Surgery 152:617–624 discussion 624–615CrossRefPubMed
13.
Baratti D, Kusamura S, Mingrone E, et al. (2012) Identification of a subgroup of patients at highest risk for complications after surgical cytoreduction and hyperthermic intraperitoneal chemotherapy. Ann Surg 256:334–341CrossRefPubMed
14.
Gilly FN, Cotte E, Brigand C, Monneuse O, Beaujard AC, Freyer G, et al. (2006) Quantitative prognostic indices in peritoneal carcinomatosis. Eur J Surg Oncol 32:597–601CrossRefPubMed
15.
Jacquet P, Sugarbaker PH (1996) Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res 82:359–374CrossRefPubMed
16.
Esquivel J, Elias D, Baratti D, Kusamura S, Deraco M (2008) Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination. J Surg Oncol 98:263–267CrossRefPubMed
17.
Elias D, Gilly F, Quenet F, et al. (2010) Pseudomyxoma peritonei: a French multicentric study of 301 patients treated with cytoreductive surgery and intraperitoneal chemotherapy. Eur J Surg Oncol 36:456–462CrossRefPubMed
18.
Elias D, Quenet F, Goere D (2012) Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma. Surg Oncol Clin N Am 21:611–623CrossRefPubMed
19.
Glehen O, Gilly FN (2003) Quantitative prognostic indicators of peritoneal surface malignancy: carcinomatosis, sarcomatosis, and peritoneal mesothelioma. Surg Oncol Clin N Am 12:649–671CrossRefPubMed
20.
González-Moreno S, González-Bayón LA, Ortega-Pérez G (2010) Hyperthermic intraperitoneal chemotherapy: rationale and technique. World J Gastrointest Oncol 2(2):68–75CrossRefPubMedPubMedCentral
21.
Glehen O, Kwiatkowski F, Sugarbaker PH, et al. (2004) Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol 22:3284–3292CrossRefPubMed
22.
Yonemura Y, Elnemr A, Endou Y, Hirano M, Mizumoto A, Takao N, Ichinose M, Miura M, Li Y (2010) Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer. World J Gastrointest Oncol 2(2):85–97CrossRefPubMedPubMedCentral
23.
Cotte E, Passot G, Gilly FN, Glehen O (2010) Selection of patients and staging of peritoneal surface malignancies. World J Gastrointest Oncol 2(1):31–35CrossRefPubMedPubMedCentral
24.
Cotte E, Benizri EI, Bernard JL, Rahili A, et al. (2012) Small bowel involvement is a prognostic factor in colorectal carcinomatosis treated with complete cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 10:56CrossRef
25.
Glockzin G, Schlitt HJ, Piso P (2009) Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. World J Surg Oncol 7:5CrossRefPubMedPubMedCentral
26.
Yan TD, Morris DL, Shigeki K, Dario B, Marcello D (2008) Preoperative investigations in the management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy: expert consensus statement. J Surg Oncol 98:224–227CrossRefPubMed
27.
Yan TD, Haveric N, Carmignani CP, Chang D, Sugarbaker PH (2005) Abdominal computed tomography scans in the selection of patients with malignant peritoneal mesothelioma for comprehensive treatment with cytoreductive surgery and perioperative intraperitoneal chemotherapy. Cancer 103:839–849CrossRefPubMed
28.
de Bree E, Koops W, Kroger R, et al. (2006) Preoperative computed tomography and selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 32:65–71CrossRefPubMed
29.
Jacquet P, Jelinek JS, Steves AM, et al. (1993) Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 72:1631–1636CrossRefPubMed
30.
de Bree E, Koops W, Kroger R, et al. (2004) Peritoneal carcinomatosis from colorectal or appendiceal origin: correlation of preoperative CT with intraoperative findings and evaluation of interobserver agreement. J Surg Oncol 86:64–73CrossRefPubMed
31.
Koh JL, Yan TD, Glenn D, Morris DL (2009) Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis. Ann Surg Oncol 16:327–333CrossRefPubMed
32.
Esquivel J, Chua TC, Stojadinovic A, et al. (2010) Accuracy and clinical relevance of computed tomography scan interpretation of peritoneal cancer index in colorectal cancer peritoneal carcinomatosis: a multi-institutional study. J Surg Oncol 102:565–570CrossRefPubMed
33.
Klumpp BD, Schwenzer N, Aschoff P, et al. (2013) Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI. Abdom Imaging 38(1):64–71CrossRefPubMed
34.
Patel CM, Sahdev A, Reznek RH (2011) MRI and PET imaging in peritoneal malignancy. Cancer Imaging 11:1231–1239CrossRef
35.
Suzuki A, Kawano T, Takahashi N, et al. (2004) Value of 18F-FDG PET in detection of peritoneal carcinomatosis. Eur J Nucl Med Mol Imaging 31:1413–1420CrossRefPubMed
36.
Passot G, Glehen AB, Pellet O, et al. (2010) Pseudomyxoma peritonei: role of 18-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction. Eur J Surg Oncol 36(3):315–323CrossRefPubMed
37.
Iversen LH, Rasmussen PC, Laurberg S (2013) Value of laparoscopy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis. Br J Surg 100:285–292CrossRefPubMed
38.
Pomel C, Appleyard TL, Gouy S, Rouzier R, Elias D (2005) The role of laparoscopy to evaluate candidates for complete cytoreduction of peritoneal carcinomatosis and hyperthermic intraperitoneal chemotherapy. Eur J Surg Oncol 31:540–543CrossRefPubMed
39.
Esquivel J, Farinetti A, Sugarbaker PH (1999) Elective surgery in recurrent colon cancer with peritoneal seeding: when and when not to proceed. G Chir 20:81–86PubMed
40.
Valle M, Federici O, Garofalo A (2012) Patient selection for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, and role of laparoscopy in diagnosis, staging, and treatment. Surg Oncol Clin N Am 21:515–531CrossRefPubMed
41.
Buyske J (2000) Role of laparoscopic-assisted techniques in staging malignant diseases. Surg Clin North Am 80:495–503CrossRefPubMed
42.
Denzen U, Hoffmann S, Helmreich-Becker I, et al. (2004) Minilaparoscopy in the diagnosis of peritoneal tumor spread: prospective controlled comparison with computed tomography. Surg Endosc 18:1067–1070
43.
Garofalo A, Valle M (2009) Laparoscopy in the management of peritoneal carcinomatosis. Cancer J 15:190–195CrossRefPubMed
44.
Garofalo A, Valle M (2003) Staging videolaparoscopy of peritoneal carcinomatosis. Tumori 89(4 suppl):70–77PubMed
45.
Valle M, Garofalo A (2006) Laparoscopic staging of peritoneal surface malignancies. Eur J Surg Oncol 32:625–627CrossRefPubMed
46.
Laterza B, Kusamura S, Baratti D, et al. (2009) Role of explorative laparoscopy to evaluate optimal candidates for cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in patients with peritoneal mesothelioma. In Vivo 23:187–190PubMed
47.
48.
Jayakrishnan TT, Zacharias AJ, Sharma A, et al. (2014) Role of laparoscopy in patients with peritoneal metastases considered for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). World J Surg Oncol 12:270CrossRefPubMedPubMedCentral
49.
Tabrizian P, Jjayakrishnan TT, Zacharias A, et al. (2015) published online Incorporation of diagnostic laparoscopy in the management algorithm for patients with peritoneal metastases: a multi-institutional analysis. J Surg Oncol. doi:10.​1002/​jso.​23924 PubMed
Metadata
Title
Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies
Authors
Ramakrishnan Ayloor Seshadri
Hemanth Raj E
Publication date
01-06-2016
Publisher
Springer India
Published in
Indian Journal of Surgical Oncology / Issue 2/2016
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI
https://doi.org/10.1007/s13193-015-0486-9

Other articles of this Issue 2/2016

Indian Journal of Surgical Oncology 2/2016 Go to the issue

Review Article

Pathology of Mucinous Appendiceal Tumors and Pseudomyxoma Peritonei

Review Article

Anaesthetic Considerations in the Perioperative Management of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Editorial Notes

Peritoneal Metastases: Prevention and Treatment

DESK OF THE EDITOR

Desk of the Editor

Review Article

Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy

Review Article

Intensive Care Management of Patient After Cytoreductive Surgery and HIPEC - A Concise Review